On February 7, 2017, Proto Script Pharmaceutical Corp. (the “Company”) and Michelle Rico (“Rico”), the Company’s sole officer and director, entered into a Share Exchange Agreement (the “Agreement”). Pursuant to the Agreement, Rico agreed to exchange 295,000,000 shares of common stock that she owns into 1,500,000 shares of Series A Preferred Stock. The Company will cancel the 295,000,000 shares of common stock and returned them back to treasury.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.